Withdrawal of skeletal muscle cells from cell cycle progression triggers differentiation of Toxoplasma gondii towards the bradyzoite stage

Cellular Microbiology

Volumn 17, Issue 1, 2015, Pages 2-17

  Swierzy, Izabela J ^a   Lüder, Carsten G K ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYZOITE ANTIGEN 1; CELL CYCLE PROTEIN; CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR 1; MYOSIN HEAVY CHAIN; PARASITE ANTIGEN; TESTIS SPECIFIC Y ENCODED LIKE PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIPROTOZOAL ACTIVITY; ARTICLE; BRADYZOITE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATIONAL STUDY; CYST (RESTING STAGE); DNA SYNTHESIS; DOWN REGULATION; FIBROBLAST; GENE; GENE SILENCING; HOST PARASITE INTERACTION; MICROBIAL MORPHOLOGY; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; MONONUCLEAR CELL; MOUSE; MULTINUCLEAR CELL; MYOBLAST; MYOTUBE; NONHUMAN; PARASITE DEVELOPMENT; PRIORITY JOURNAL; PROTOZOAL TRANSFORMATION; RNA INTERFERENCE; SKELETAL MUSCLE; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; TSPYL2 GENE; UPREGULATION; ANIMAL; CELL CYCLE; CELL LINE; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; MUSCLE CELL; PARASITOLOGY; PHYSIOLOGY; TOXOPLASMA;

AVES; MAMMALIA; TOXOPLASMA; TOXOPLASMA GONDII;

ANIMALS; CELL CYCLE; CELL LINE; FIBROBLASTS; HOST-PATHOGEN INTERACTIONS; MICE; MUSCLE CELLS; TOXOPLASMA;

EID: 84918834080     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12342     Document Type: Article

References (45)

1. Bentzinger, C.F., Wang, Y.X., and Rudnicki, M.A. (2012) Building muscle: molecular regulation of myogenesis. Cold Spring Harb Perspect Biol 4: a008342.
2. Blader, I.J., Manger, I.D., and Boothroyd, J.C. (2001) Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. J Biol Chem 276: 24223-24231.
3. Bohne, W., Heesemann, J., and Gross, U. (1994) Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun 62: 1761-1767.
4. Bougdour, A., Maubon, D., Baldacci, P., Ortet, P., Bastien, O., Bouillon, A., etal. (2009) Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites. J Exp Med 206: 953-966.
5. Brunet, J., Pfaff, A.W., Abidi, A., Unoki, M., Nakamura, Y., Guinard, M., etal. (2008) Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation. Cell Microbiol 10: 908-920.
6. Chai, Z., Sarcevic, B., Mawson, A., and Toh, B.H. (2001) SET-related cell division autoantigen-1 (CDA1) arrests cell growth. J Biol Chem 276: 33665-33674.
7. Chaudhary, K., Darling, J.A., Fohl, L.M., Sullivan, W.J., Jr, Donald, R.G., Pfefferkorn, E.R., etal. (2004) Purine salvage pathways in the apicomplexan parasite Toxoplasma gondii. J Biol Chem 279: 31221-31227.
8. Cook, A.J., Gilbert, R.E., Buffolano, W., Zufferey, J., Petersen, E., Jenum, P.A., etal. (2000) Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 321: 142-147.
9. Dubey, J.P., Lindsay, D.S., and Speer, C.A. (1998) Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 11: 267-299.
10. Dzierszinski, F., Nishi, M., Ouko, L., and Roos, D.S. (2004) Dynamics of Toxoplasma gondii differentiation. Eukaryot Cell 3: 992-1003.
11. Ferguson, D.J. (2004) Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host. Int J Parasitol 34: 347-360.
12. Ferguson, D.J., and Hutchison, W.M. (1987) The host-parasite relationship of Toxoplasma gondii in the brains of chronically infected mice. Virchows Arch A Pathol Anat Histopathol 411: 39-43.
13. Ferreira-da-Silva Mda, F., Barbosa, H.S., Gross, U., and Lüder, C.G. (2008) Stress-related and spontaneous stage differentiation of Toxoplasma gondii. Mol Biosyst 4: 824-834.
14. Ferreira-da-Silva Mda, F., Takacs, A.C., Barbosa, H.S., Gross, U., and Luder, C.G. (2009) Primary skeletal muscle cells trigger spontaneous Toxoplasma gondii tachyzoite-to-bradyzoite conversion at higher rates than fibroblasts. Int J Med Microbiol 299: 381-388.
15. Gross, U., Muller, W.A., Knapp, S., and Heesemann, J. (1991) Identification of a virulence-associated antigen of Toxoplasma gondii by use of a mouse monoclonal antibody. Infect Immun 59: 4511-4516.
16. Gross, U., Bormuth, H., Gaissmaier, C., Dittrich, C., Krenn, V., Bohne, W., and Ferguson, D.J. (1995) Monoclonal rat antibodies directed against Toxoplasma gondii suitable for studying tachyzoite-bradyzoite interconversion in vivo. Clin Diagn Lab Immunol 2: 542-548.
17. Guimaraes, E.V., de Carvalho, L., and Barbosa, H.S. (2008) Primary culture of skeletal muscle cells as a model for studies of Toxoplasma gondii cystogenesis. J Parasitol 94: 72-83.
18. Guo, K., Wang, J., Andres, V., Smith, R.C., and Walsh, K. (1995) MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 15: 3823-3829.
19. Halevy, O., Novitch, B.G., Spicer, D.B., Skapek, S.X., Rhee, J., Hannon, G.J., etal. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
20. Homan, W.L., Vercammen, M., De Braekeleer, J., and Verschueren, H. (2000) Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol 30: 69-75.
21. Huang, J., and Thayer, M.J. (2002) Interactions between the cell cycle and the myogenic program. In Advances in Developmental Biology and Biochemistry. Sassoon, D. (ed.). Amsterdam: Elsevier, pp. 53-74.
22. Jerome, M.E., Radke, J.R., Bohne, W., Roos, D.S., and White, M.W. (1998) Toxoplasma gondii bradyzoites form spontaneously during sporozoite-initiated development. Infect Immun 66: 4838-4844.
23. Jones, J.L., Dargelas, V., Roberts, J., Press, C., Remington, J.S., and Montoya, J.G. (2009) Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 49: 878-884.
24. Li, Y., and Lau, Y.F. (2008) TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities. Oncogene 27: 6141-6150.
25. Lin, C.W., Huang, T.N., Wang, G.S., Kuo, T.Y., Yen, T.Y., and Hsueh, Y.P. (2006) Neural activity- and development-dependent expression and distribution of CASK interacting nucleosome assembly protein in mouse brain. J Comp Neurol 494: 606-619.
26. Lüder, C.G., Stanway, R.R., Chaussepied, M., Langsley, G., and Heussler, V.T. (2009) Intracellular survival of apicomplexan parasites and host cell modification. Int J Parasitol 39: 163-173.
27. Mahamed, D.A., Mills, J.H., Egan, C.E., Denkers, E.Y., and Bynoe, M.S. (2012) CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system. Proc Natl Acad Sci USA 109: 16312-16317.
28. Molestina, R.E., El-Guendy, N., and Sinai, A.P. (2008) Infection with Toxoplasma gondii results in dysregulation of the host cell cycle. Cell Microbiol 10: 1153-1165.
29. Nagamune, K., Hicks, L.M., Fux, B., Brossier, F., Chini, E.N., and Sibley, L.D. (2008) Abscisic acid controls calcium-dependent egress and development in Toxoplasma gondii. Nature 451: 207-210.
30. Nurse, P. (2000) A long twentieth century of the cell cycle and beyond. Cell 100: 71-78.
31. Radke, J.R., Guerini, M.N., Jerome, M., and White, M.W. (2003) A change in the premitotic period of the cell cycle is associated with bradyzoite differentiation in Toxoplasma gondii. Mol Biochem Parasitol 131: 119-127.
32. Radke, J.R., Behnke, M.S., Mackey, A.J., Radke, J.B., Roos, D.S., and White, M.W. (2005) The transcriptome of Toxoplasma gondii. BMC Biol 3: 26.
33. Radke, J.R., Donald, R.G., Eibs, A., Jerome, M.E., Behnke, M.S., Liberator, P., and White, M.W. (2006) Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development. PLoS Pathog 2: e105.
34. Schwartzman, J.D., and Pfefferkorn, E.R. (1982) Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites. Exp Parasitol 53: 77-86.
35. Starostina, N.G., and Kipreos, E.T. (2012) Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol 22: 33-41.
36. Swierzy, I.J., Muhammad, M., Kroll, J., Abelmann, A., Tenter, A.M., and Luder, C.G. (2014) Toxoplasma gondii within skeletal muscle cells: a critical interplay for food-borne parasite transmission. Int J Parasitol 44: 91-98.
37. Takacs, A.C., Swierzy, I.J., and Luder, C.G. (2012) Interferon-gamma restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immunity-related GTPases. PLoS ONE 7: e45440.
38. Tanaka, K., Sato, K., Yoshida, T., Fukuda, T., Hanamura, K., Kojima, N., etal. (2011) Evidence for cell density affecting C2C12 myogenesis: possible regulation of myogenesis by cell-cell communication. Muscle Nerve 44: 968-977.
39. Tao, K.P., Fong, S.W., Lu, Z., Ching, Y.P., Chan, K.W., and Chan, S.Y. (2011) TSPYL2 is important for G1 checkpoint maintenance upon DNA damage. PLoS ONE 6: e21602.
40. Tu, Y., Wu, W., Wu, T., Cao, Z., Wilkins, R., Toh, B.H., etal. (2007) Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways. J Biol Chem 282: 11722-11731.
41. Vutova, P., Wirth, M., Hippe, D., Gross, U., Schulze-Osthoff, K., Schmitz, I., and Lüder, C.G. (2007) Toxoplasma gondii inhibits Fas/CD95-triggered cell death by inducing aberrant processing and degradation of caspase 8. Cell Microbiol 9: 1556-1570.
42. Wang, G.S., Hong, C.J., Yen, T.Y., Huang, H.Y., Ou, Y., Huang, T.N., etal. (2004) Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron 42: 113-128.
43. Weilhammer, D.R., Iavarone, A.T., Villegas, E.N., Brooks, G.A., Sinai, A.P., and Sha, W.C. (2012) Host metabolism regulates growth and differentiation of Toxoplasma gondii. Int J Parasitol 42: 947-959.
44. Wiendl, H., Hohlfeld, R., and Kieseier, B.C. (2005) Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol 26: 373-380.
45. Yoshida, N., Yoshida, S., Koishi, K., Masuda, K., and Nabeshima, Y. (1998) Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci 111 (Part 6): 769-779.